| SC 13D/A | 2017-01-09 | BAKER BROS. ADVISORS LP | AQUINOX PHARMACEUTICALS, INC | 10,934,154 | 46.7% | EDGAR |
| SC 13G | 2016-10-11 | PRICE T ROWE ASSOCIATES INC /MD/ | AQUINOX PHARMACEUTICALS, INC | 3,259,367 | 14.4% | EDGAR |
| SC 13D/A | 2016-09-21 | BAKER BROS. ADVISORS LP | AQUINOX PHARMACEUTICALS, INC | 10,536,092 | 45.1% | EDGAR |
| SC 13D/A | 2016-03-16 | BAKER BROS. ADVISORS LP | AQUINOX PHARMACEUTICALS, INC | 7,752,487 | 45.0% | EDGAR |
| SC 13G/A | 2016-02-16 | RA CAPITAL MANAGEMENT, LLC | AQUINOX PHARMACEUTICALS, INC | 1,619,977 | 9.4% | EDGAR |
| SC 13G | 2016-02-16 | Ventures West 8 Limited Partnership | AQUINOX PHARMACEUTICALS, INC | 1,020,430 | 5.9% | EDGAR |
| SC 13G/A | 2016-02-12 | JOHNSON & JOHNSON | AQUINOX PHARMACEUTICALS, INC | 0 | 0.0% | EDGAR |
| SC 13G/A | 2016-02-12 | Augment Investments Ltd. | AQUINOX PHARMACEUTICALS, INC | 247,111 | 1.4% | EDGAR |
| SC 13G/A | 2016-02-12 | Visium Asset Management, LP | AQUINOX PHARMACEUTICALS, INC | 1,400,000 | 8.1% | EDGAR |
| SC 13G/A | 2016-02-03 | FRANKLIN RESOURCES INC | AQUINOX PHARMACEUTICALS, INC | 1,158,345 | 6.7% | EDGAR |
| SC 13G | 2016-01-28 | BlackRock Inc. | AQUINOX PHARMACEUTICALS, INC | 903,693 | 5.3% | EDGAR |
| SC 13D/A | 2016-01-20 | BAKER BROS. ADVISORS LP | AQUINOX PHARMACEUTICALS, INC | 7,140,034 | 41.5% | EDGAR |
| SC 13D/A | 2016-01-15 | BAKER BROS. ADVISORS LP | AQUINOX PHARMACEUTICALS, INC | 6,949,955 | 40.4% | EDGAR |
| SC 13G | 2015-09-21 | Visium Asset Management, LP | AQUINOX PHARMACEUTICALS, INC | 1,400,000 | 8.6% | EDGAR |
| SC 13D/A | 2015-09-11 | BAKER BROS. ADVISORS LP | AQUINOX PHARMACEUTICALS, INC | 6,747,332 | 39.6% | EDGAR |
| SC 13G | 2015-08-24 | RA CAPITAL MANAGEMENT, LLC | AQUINOX PHARMACEUTICALS, INC | 1,032,151 | 9.6% | EDGAR |
| SC 13G/A | 2015-08-18 | PFIZER INC | AQUINOX PHARMACEUTICALS, INC | 481,529 | 4.5% | EDGAR |
| SC 13D/A | 2015-08-11 | BAKER BROS. ADVISORS LP | AQUINOX PHARMACEUTICALS, INC | 4,267,300 | 39.8% | EDGAR |
| SC 13D | 2015-08-10 | BAKER BROS. ADVISORS LP | AQUINOX PHARMACEUTICALS, INC | 4,267,300 | 39.8% | EDGAR |
| SC 13G/A | 2015-02-17 | BAKER BROS. ADVISORS LP | AQUINOX PHARMACEUTICALS, INC | 1,210,350 | 11.3% | EDGAR |